Phibro Animal Health Corporation (PAHC) has a MoatMap StockRank of 75/100 based on Quality (64/100), Value (49/100), and Momentum (45/100) factor scores. The current signal is BUY. Phibro Animal Health operates in animal nutrition and health. While a decent business, it lacks a powerful macro tailwind or structural pricing power to drive asymmetric returns over our 18-month horizon.
Phibro Animal Health Corporation is a U.S.-based company developing, manufacturing, and marketing a diverse portfolio of animal health and nutrition products, including medicated feed additives, vaccines, and nutritional supplements. The company's competitive moat is built on its extensive industry experience, strong relationships with livestock producers, and a broad product offering vital for animal productivity and disease prevention. This integrated approach solidifies its position in the global animal health market.
| Price | $31.79 |
| Market Cap | $1.3B |
| P/E (TTM) | 14.18 |
| P/E (Forward) | 9.88 |
| Price/Book | 3.70 |
| Return on Equity | 30.3% |
| Return on Invested Capital | 9.5% |
| Debt/Equity | 217.97 |
| Gross Margin | 32.6% |
| Operating Margin | 12.6% |
| Revenue Growth | 10.3% |
| Dividend Yield | 1.4% |
| Free Cash Flow | $-18M |
Phibro Animal Health Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).